Yesterday, the FDA approved a medical device terminally sterilized by Noxilizer's nitrogen dioxide sterilization process.
Here are three things to know about the company:
- Baltimore-based Noxilizer provides room-temperature sterilization technology, selling its nitrogen dioxide sterilization equipment to pharmaceutical, biotech and medical device manufacturers.
- Nitrogen dioxide sterilization is unique because it sterilizes at low temperatures of 50 to 86 degrees Fahrenheit and functions with or without vacuum and humidity. These factors prove significant for the growing number of biotech drugs and temperature-sensitive medical devices in the industry.
- Noxilizer says the nitrogen dioxide sterilization process allows companies to safely bring sterilization back in house, greatly reducing process time and saving up to 50 percent or more in operational costs.
More articles on supply chain:
FDA approves first blood test to detect genetic mutation associated with lung cancer
Florida amends hepatitis C drug policy for Medicaid following lawsuit
FDA issues final guidance over post-market surveillance for medical devices